Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference The new mini-textbook by Kamps & Hoffmann PDF, 110 pages

Colorectal Neoplasms

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 253 articles: HTML format Text format

Single Articles

April 2020
1. WATANABE D, Fujii H, Matsuhashi N, Iihara H, et al
   Dose Adjustment of Oxaliplatin Based on Renal Function in Patients With Metastatic Colorectal Cancer.
   Anticancer Res. 2020;40:2379-2386.
   PubMed     Text format     Abstract available
   
   
   
2. ASHIZAWA N, Furuya S, Katsutoshi S, Sudo M, et al
   Clinical Significance of Dynamic Neutrophil-lymphocyte Ratio Changes in Patients With Colorectal Cancer.
   Anticancer Res. 2020;40:2311-2317.
   PubMed     Text format     Abstract available
   
   
   
3. HIGASHINO N, Matsuda T, Hasegawa H, Yamashita K, et al
   Outcomes of Laparoscopic Surgery in Colorectal Cancer Patients With Dialysis.
   Anticancer Res. 2020;40:2165-2170.
   PubMed     Text format     Abstract available
   
   
   March 2020
4. KOJIMA T, Hino H, Shiomi A, Kagawa H, et al
   Surgical Outcomes of Laparoscopic and Open D3 Dissection for Clinical Stage II/III Descending Colon Cancer.
   Anticancer Res. 2020;40:1731-1737.
   PubMed     Text format     Abstract available
   
   
   
5. WANG L, Hirano Y, Heng G, Ishii T, et al
   Mucinous Adenocarcinoma as a High-risk Factor in Stage II Colorectal Cancer: A Propensity Score-matched Study from Japan.
   Anticancer Res. 2020;40:1651-1659.
   PubMed     Text format     Abstract available
   
   
   
6. KIMURA M, Usami E, Teramachi H, Yoshimura T, et al
   Risk Benefit of FOLFIRI Plus Ramucirumab as Third-line and Later-line Treatment of Metastatic Colorectal Cancer.
   Anticancer Res. 2020;40:1605-1611.
   PubMed     Text format     Abstract available
   
   
   
7. KIM HJ, Han YS, Lee JH, Lee SH, et al
   Casein Kinase 2alpha Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress.
   Anticancer Res. 2020;40:1419-1426.
   PubMed     Text format     Abstract available
   
   
   
8. SARHADI V, Lahti L, Saberi F, Youssef O, et al
   Gut Microbiota and Host Gene Mutations in Colorectal Cancer Patients and Controls of Iranian and Finnish Origin.
   Anticancer Res. 2020;40:1325-1334.
   PubMed     Text format     Abstract available
   
   
   
9. HUNG YC, Chang WS, Chou AK, Pei JS, et al
   Association of Adiponectin Genotypes With Colorectal Cancer Susceptibility in Taiwan.
   Anticancer Res. 2020;40:1297-1306.
   PubMed     Text format     Abstract available
   
   
   
10. HURLEY PJ, Bose N, Jha G, Gargano M, et al
    Immunoglobulin Restores Immune Responses to BTH1677 in Patients With Low Levels of Antibodies to Beta-glucan.
    Anticancer Res. 2020;40:1467-1473.
    PubMed     Text format     Abstract available
    
    
    February 2020
11. YUN SH, Park JI
    COUP-TFII Overexpression Inhibits Cell Proliferation and Invasion via Increased Expression of p53 and PTEN and Decreased Akt Phosphorylation in Human Colorectal Cancer SNU-C4 Cells.
    Anticancer Res. 2020;40:767-777.
    PubMed     Text format     Abstract available
    
    
    
12. YUN SH, Park JI
    PGC-1alpha Regulates Cell Proliferation and Invasion via AKT/GSK-3beta/beta-catenin Pathway in Human Colorectal Cancer SW620 and SW480 Cells.
    Anticancer Res. 2020;40:653-664.
    PubMed     Text format     Abstract available
    
    
    
13. MEKLIN J, Syrjanen K, Eskelinen M
    Colorectal Cancer Screening With Traditional and New-generation Fecal Immunochemical Tests: A Critical Review of Fecal Occult Blood Tests.
    Anticancer Res. 2020;40:575-581.
    PubMed     Text format     Abstract available
    
    
    
14. NAKAMOTO T, Hokuto D, Nomi T, Yoshikawa T, et al
    Characteristics of Five-year Survivors After Liver Resection for Colorectal Liver Metastases in Modern Chemotherapy.
    Anticancer Res. 2020;40:1107-1116.
    PubMed     Text format     Abstract available
    
    
    January 2020
15. RYU S, Suwa K, Kitagawa T, Aizawa M, et al
    Evaluation of Anastomosis With ICG Fluorescence Method Using VISERA ELITE2 During Laparoscopic Colorectal Cancer Surgery.
    Anticancer Res. 2020;40:373-377.
    PubMed     Text format     Abstract available
    
    
    
16. WATANABE D, Fujii H, Yamada Y, Iihara H, et al
    Relationship Between Renal Function and the Incidence of Adverse Events in Patients With Colorectal Cancer Receiving Oxaliplatin.
    Anticancer Res. 2020;40:299-304.
    PubMed     Text format     Abstract available
    
    
    
17. HAUS R, Janssen S, Schild SE, Rades D, et al
    A Disease-specific Score for Estimating Survival After Irradiation of Bone Metastases from Colorectal Cancer.
    Anticancer Res. 2020;40:287-291.
    PubMed     Text format     Abstract available
    
    
    
18. HIRABAYASHI S, Hayashi M, Nakayama G, Mii S, et al
    The Significance of Molecular Biomarkers on Clinical Survival Outcome Differs Depending on Colon Cancer Sidedness.
    Anticancer Res. 2020;40:201-211.
    PubMed     Text format     Abstract available
    
    
    
19. YUN SH, Han SH, Park JI
    COUP-TFII Knock-down Promotes Proliferation and Invasion in Colorectal Cancer Cells via Activation of Akt Pathway and Up-regulation of FOXC1.
    Anticancer Res. 2020;40:177-190.
    PubMed     Text format     Abstract available
    
    
    
20. TANAKA T, Kobunai T, Yamamoto Y, Murono K, et al
    Assessment of the Changes in Mitochondrial Gene Polymorphism in Ulcerative Colitis and the Etiology of Ulcerative Colitis-associated Colorectal Cancer.
    Anticancer Res. 2020;40:101-107.
    PubMed     Text format     Abstract available
    
    
    
21. OKUYAMA H, Nogami W, Sato Y, Yoshida H, et al
    Characterization of CD44-positive Cancer Stem-like Cells in COLO 201 Cells.
    Anticancer Res. 2020;40:169-176.
    PubMed     Text format     Abstract available
    
    
    
22. DORR NM, Bartels M, Morgul MH
    Current Treatment of Colorectal Liver Metastasis as a Chronic Disease.
    Anticancer Res. 2020;40:1-7.
    PubMed     Text format     Abstract available
    
    
    December 2019
23. TANAKA H, Kawaguchi M, Shoda S, Miyoshi T, et al
    Nuclear Accumulation of beta-Catenin in Cancer Stem Cell Radioresistance and Stemness in Human Colon Cancer.
    Anticancer Res. 2019;39:6575-6583.
    PubMed     Text format     Abstract available
    
    
    
24. WU MH, Tzeng HE, Wu CN, Yueh TC, et al
    Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk.
    Anticancer Res. 2019;39:6523-6529.
    PubMed     Text format     Abstract available
    
    
    
25. ZHU G, Zhao M, Han Q, Tan Y, et al
    Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model.
    Anticancer Res. 2019;39:6463-6470.
    PubMed     Text format     Abstract available
    
    
    
26. OGINO Y, Sato A, Kawano Y, Aoyama T, et al
    Association of ABC Transporter With Resistance to FK866, a NAMPT Inhibitor, in Human Colorectal Cancer Cells.
    Anticancer Res. 2019;39:6457-6462.
    PubMed     Text format     Abstract available
    
    
    
27. PETRELLI F, Ghidini M, Cabiddu M, Pezzica E, et al
    Microsatellite Instability and Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis.
    Anticancer Res. 2019;39:6431-6441.
    PubMed     Text format     Abstract available
    
    
    
28. DE FELICE F, Siniscalchi B, Bulzonetti N, Caiazzo R, et al
    Tolerability of Oxaliplatin-based Neoadjuvant Chemoradiotherapy in Elderly Locally Advanced Rectal Cancer Patients: A Case-control Study of a Real-life Experience.
    Anticancer Res. 2019;39:6957-6963.
    PubMed     Text format     Abstract available
    
    
    
29. FIORI E, Crocetti D, Lamazza A, DE Felice F, et al
    Resection or Stenting in the Treatment of Symptomatic Advanced Metastatic Rectal Cancer: A Dilemma.
    Anticancer Res. 2019;39:6781-6786.
    PubMed     Text format     Abstract available
    
    
    
30. CIZMARIKOVA M, Takac P, Spengler G, Kincses A, et al
    New Chalcone Derivative Inhibits ABCB1 in Multidrug Resistant T-cell Lymphoma and Colon Adenocarcinoma Cells.
    Anticancer Res. 2019;39:6499-6505.
    PubMed     Text format     Abstract available
    
    
    
31. SOHN M, Agha A, Trum S, Moser C, et al
    Frequency of Polyps and Adenocarcinoma in Colon Interposition After Esophagectomy in Adulthood - A Systematic Review.
    Anticancer Res. 2019;39:6419-6430.
    PubMed     Text format     Abstract available
    
    
    November 2019
32. KAYANO H, Nomura E, Ueda Y, Kuramoto T, et al
    Short- and Long-term Outcomes of 2-Step Stapled Intracorporeal Versus Extracorporeal Anastomosis in Laparoscopic Colectomy for Colon Cancer.
    Anticancer Res. 2019;39:6393-6401.
    PubMed     Text format     Abstract available
    
    
    
33. KATAFYGIOTIS P, Sakellariou S, Chatziandreou I, Giannopoulou I, et al
    Microsatellite Instability in Greek Colorectal Carcinoma Patients: Clinicopathological and Molecular Correlations.
    Anticancer Res. 2019;39:6379-6387.
    PubMed     Text format     Abstract available
    
    
    
34. HORIUCHI T, Haruki K, Shiba H, Sakamoto T, et al
    Assessment of Outcome of Hepatic Resection for Extremely Elderly Patients With a Hepatic Malignancy.
    Anticancer Res. 2019;39:6325-6332.
    PubMed     Text format     Abstract available
    
    
    
35. HO ML, Kuo WK, Chu LJ, Yeh IH, et al
    N-acetylgalactosamine-6-sulfatase (GALNS), Similar to Glycodelin, Is a Potential General Biomarker for Multiple Malignancies.
    Anticancer Res. 2019;39:6317-6324.
    PubMed     Text format     Abstract available
    
    
    
36. PALAIOLOGOS P, Chrysikos D, Theocharis S, Kouraklis G, et al
    The Prognostic Value of G1 Cyclins, p21 and Rb Protein in Patients With Colon Cancer.
    Anticancer Res. 2019;39:6291-6297.
    PubMed     Text format     Abstract available
    
    
    
37. TREDER M, Janssen S, Schild SE, Rades D, et al
    Results of Tri-Modality Therapy for Rectal Cancer in Elderly Patients.
    Anticancer Res. 2019;39:6217-6222.
    PubMed     Text format     Abstract available
    
    
    
38. WU CC, Lai PY, Hsieh S, Cheng CC, et al
    Suppression of Carnosine on Adhesion and Extravasation of Human Colorectal Cancer Cells.
    Anticancer Res. 2019;39:6135-6144.
    PubMed     Text format     Abstract available
    
    
    
39. CHANDIMALI N, Sun HN, Kong LZ, Zhen X, et al
    Shikonin-induced Apoptosis of Colon Cancer Cells Is Reduced by Peroxiredoxin V Expression.
    Anticancer Res. 2019;39:6115-6123.
    PubMed     Text format     Abstract available
    
    
    
40. KIM HB, Lim HJ, Lee HJ, Park JH, et al
    Evaluation and Clinical Significance of Jagged-1-activated Notch Signaling by APEX1 in Colorectal Cancer.
    Anticancer Res. 2019;39:6097-6105.
    PubMed     Text format     Abstract available
    
    
    
41. VYCITAL O, Pitule P, Hosek P, Kriz T, et al
    Expression of Serpin B9 as a Prognostic Factor of Colorectal Cancer.
    Anticancer Res. 2019;39:6063-6066.
    PubMed     Text format     Abstract available
    
    
    
42. BUNDSCHERER AC, Ullrich V, Malsy M, Gruber MA, et al
    Effects of Volatile Anesthetics on Proliferation and Viability of SW480 Colon Cancer Cells In Vitro.
    Anticancer Res. 2019;39:6049-6055.
    PubMed     Text format     Abstract available
    
    
    
43. ZHU G, Zhao M, Han Q, Tan Y, et al
    Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model.
    Anticancer Res. 2019;39:5999-6005.
    PubMed     Text format     Abstract available
    
    
    
44. LEHTOMAKI KI, Lahtinen LI, Rintanen N, Kuopio T, et al
    Clonal Evolution of MEK/MAPK Pathway Activating Mutations in a Metastatic Colorectal Cancer Case.
    Anticancer Res. 2019;39:5867-5877.
    PubMed     Text format     Abstract available
    
    
    
45. CUMBO M, Tomic B, Dunjic S, Jovanovic T, et al
    Prothrombin 3'end Gene Variants in Patients With Sporadic Colon Adenocarcinoma.
    Anticancer Res. 2019;39:6067-6071.
    PubMed     Text format     Abstract available
    
    
    October 2019
46. NEKI K, Eto K, Kosuge M, Ohkuma M, et al
    Identification of the Risk Factors for Recurrence of Stage III Colorectal Cancer.
    Anticancer Res. 2019;39:5721-5724.
    PubMed     Text format     Abstract available
    
    
    
47. FIALA O, Ostasov P, Hosek P, Sorejs O, et al
    The Predictive Role of Primary Tumour Sidedness in Metastatic Colorectal Cancer Treated With Targeted Agents.
    Anticancer Res. 2019;39:5645-5652.
    PubMed     Text format     Abstract available
    
    
    
48. QIU Z, Andrijauskaite K, Morris J, Wargovich MJ, et al
    Disruption of Epigenetic Silencing in Human Colon Cancer Cells Lines Utilizing a Novel Supercritical CO2 Extract of Neem Leaf (Azadirachta indica).
    Anticancer Res. 2019;39:5473-5481.
    PubMed     Text format     Abstract available
    
    
    
49. UETA K, Matsuda T, Yamashita K, Hasegawa H, et al
    Treatment Strategy for Rectal Cancer Patients With Inguinal Lymph Node Metastasis.
    Anticancer Res. 2019;39:5767-5772.
    PubMed     Text format     Abstract available
    
    
    
50. SHIBUYA N, Matsuda T, Yamashita K, Hasegawa H, et al
    Clinical Significance of Intraoperative Colonoscopy for Anastomotic Assessment in Rectal Cancer Surgery.
    Anticancer Res. 2019;39:5761-5765.
    PubMed     Text format     Abstract available
    
    
    September 2019
51. SHIBUTANI M, Nagahara H, Fukuoka T, Iseki Y, et al
    Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
    Anticancer Res. 2019;39:5039-5045.
    PubMed     Text format     Abstract available
    
    
    
52. DIMBERG J, Shamoun L, Landerholm K, Andersson RE, et al
    Genetic Variants of the IL2 Gene Related to Risk and Survival in Patients With Colorectal Cancer.
    Anticancer Res. 2019;39:4933-4940.
    PubMed     Text format     Abstract available
    
    
    
53. SIGNORELLI C, Chilelli MG, Sperduti I, Giacinti S, et al
    Correlation of Tumor Location to Clinical Outcomes in Colorectal Cancer: A Single-institution Retrospective Analysis.
    Anticancer Res. 2019;39:4917-4924.
    PubMed     Text format     Abstract available
    
    
    
54. SEATON ME, Peters U, Johnson KC, Kooperberg C, et al
    Effects of Colorectal Cancer Risk Factors on the Association Between Aspirin and Colorectal Cancer.
    Anticancer Res. 2019;39:4877-4884.
    PubMed     Text format     Abstract available
    
    
    
55. YUN CW, Lee JH, Lee SH
    Hypoxia-induced PGC-1alpha Regulates Mitochondrial Function and Tumorigenesis of Colorectal Cancer Cells.
    Anticancer Res. 2019;39:4865-4876.
    PubMed     Text format     Abstract available
    
    
    
56. HA YJ, Tak KH, Kim SK, Kim CW, et al
    Biological Characteristics and Clinical Significance of ITGB1 and RHOC in Patients With Recurrent Colorectal Cancer.
    Anticancer Res. 2019;39:4853-4864.
    PubMed     Text format     Abstract available
    
    
    
57. KURAMOCHI H, Nakajima GO, Hayashi K, Araida T, et al
    Amphiregulin/epiregulin mRNA Expression and Primary Tumor Location in Colorectal Cancer.
    Anticancer Res. 2019;39:4729-4736.
    PubMed     Text format     Abstract available
    
    
    
58. OSHIRO H, Tome Y, Kiyuna T, Yoon SN, et al
    Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model.
    Anticancer Res. 2019;39:4667-4671.
    PubMed     Text format     Abstract available
    
    
    
59. OHARA T, Mori T
    Antiproliferative Effects of Short-chain Fatty Acids on Human Colorectal Cancer Cells via Gene Expression Inhibition.
    Anticancer Res. 2019;39:4659-4666.
    PubMed     Text format     Abstract available
    
    
    
60. FUKUOKA T, Maeda K, Nagahara H, Shibutani M, et al
    Change in PMI During Neoadjuvant Therapy Is a Predictive Prognostic Marker in Rectal Cancer.
    Anticancer Res. 2019;39:5157-5163.
    PubMed     Text format     Abstract available
    
    
    
61. ISKANDER O, Courtot L, Tabchouri N, Artus A, et al
    Complete Pathological Response Following Radiochemotherapy for Locally Advanced Rectal Cancer: Short and Long-term Outcome.
    Anticancer Res. 2019;39:5105-5113.
    PubMed     Text format     Abstract available
    
    
    
62. KOMORI K, Kinoshita T, Oshiro T, Ouchi A, et al
    Surgical Strategy for Rectovaginal Fistula After Colorectal Anastomosis at a High-volume Cancer Center According to Image Type and Colonoscopy Findings.
    Anticancer Res. 2019;39:5097-5103.
    PubMed     Text format     Abstract available
    
    
    
63. MORINE Y, Ikemoto T, Iwahashi S, Saito YU, et al
    Clinical Impact of FOLFOXIRI Aiming for Conversion Surgery in Unresectable Multiple Colorectal Liver Metastasis.
    Anticancer Res. 2019;39:5089-5096.
    PubMed     Text format     Abstract available
    
    
    
64. RUBIO CA, Schmidt PT
    The Normal Epithelium of Crypts Accruing Below Nonpolypoid Adenomas Thrives With Relocated Proliferating Cell-domains and p53-Up-regulated Cells.
    Anticancer Res. 2019;39:4965-4970.
    PubMed     Text format     Abstract available
    
    
    
65. LUCERI C, Femia AP, D'Ambrosio M, Caderni G, et al
    High Sensitivity to Cholic Acid-induced Colonic Tumorigenesis Makes Female PIRC Rats (F344/NTac-Apc(am1137)) a Suitable Model for Studying CRC-promoting Agents.
    Anticancer Res. 2019;39:4673-4679.
    PubMed     Text format     Abstract available
    
    
    August 2019
66. HISAKA T, Ishikawa H, Sakai H, Kawahara R, et al
    Sinusoidal Obstruction Syndrome and Postoperative Complications Resulting from Preoperative Chemotherapy for Colorectal Cancer Liver Metastasis.
    Anticancer Res. 2019;39:4549-4554.
    PubMed     Text format     Abstract available
    
    
    
67. TAKIMOTO R, Kamigaki T, Okada S, Matsuda E, et al
    Prognostic Factors for Colorectal Cancer Patients Treated With Combination of Immune-cell Therapy and First-line Chemotherapy: A Retrospective Study.
    Anticancer Res. 2019;39:4525-4532.
    PubMed     Text format     Abstract available
    
    
    
68. ASHIZAWA N, Shimizu H, Sudo M, Furuya S, et al
    Clinical Significance of NADPH Oxidase 5 in Human Colon Cancer.
    Anticancer Res. 2019;39:4405-4410.
    PubMed     Text format     Abstract available
    
    
    
69. MATSUDA A, Yamada T, Matsumoto S, Sakurazawa N, et al
    Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival After TAS-102 Treatment of Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2019;39:4343-4350.
    PubMed     Text format     Abstract available
    
    
    
70. ITO Y, Kobuchi S, Takesada W, Takahashi C, et al
    Assessment of Oxaliplatin-induced Chronic Neuropathy and Anticancer Efficacy Through Pharmacokinetic and Toxicodynamic Evaluation of a Rat Model of Colorectal Cancer.
    Anticancer Res. 2019;39:4207-4213.
    PubMed     Text format     Abstract available
    
    
    
71. YOON SN, Park JH, Lwin TM, Miyake K, et al
    Tumor-sealing Surgical Orthotopic Implantation of Human Colon Cancer in Nude Mice Induces Clinically-relevant Metastases Without Early Peritoneal Carcinomatosis.
    Anticancer Res. 2019;39:4065-4071.
    PubMed     Text format     Abstract available
    
    
    
72. NAYERI M, Iskander O, Tabchouri N, Artus A, et al
    Low Tie Compared to High Tie Vascular Ligation of the Inferior Mesenteric Artery in Rectal Cancer Surgery Decreases Postoperative Complications Without Affecting Overall Survival.
    Anticancer Res. 2019;39:4363-4370.
    PubMed     Text format     Abstract available
    
    
    
73. RUBIO CA, Schmidt PT
    Dissecting the Microscopic Anatomy of Colon Crypts in Non-dysplastic Sessile Serrated Polyps.
    Anticancer Res. 2019;39:4259-4263.
    PubMed     Text format     Abstract available
    
    
    July 2019
74. GIULIANI J, Bonetti A
    The Onset of Grade >/=3 Neutropenia Is Associated With Longer Overall Survival in Metastatic Colorectal Cancer Patients Treated With Trifluridine/Tipiracil.
    Anticancer Res. 2019;39:3967-3969.
    PubMed     Text format     Abstract available
    
    
    
75. CZUMAJ A, Zabielska J, Pakiet A, Mika A, et al
    In Vivo Effectiveness of Orlistat in the Suppression of Human Colorectal Cancer Cell Proliferation.
    Anticancer Res. 2019;39:3815-3822.
    PubMed     Text format     Abstract available
    
    
    
76. LIU Y, Kwon T, Kim JS, Chandimali N, et al
    Peroxiredoxin V Reduces beta-Lapachone-induced Apoptosis of Colon Cancer Cells.
    Anticancer Res. 2019;39:3677-3686.
    PubMed     Text format     Abstract available
    
    
    
77. KIM JY, Park G, Krishnan M, Ha E, et al
    Selective Wnt/beta-catenin Small-molecule Inhibitor CWP232228 Impairs Tumor Growth of Colon Cancer.
    Anticancer Res. 2019;39:3661-3667.
    PubMed     Text format     Abstract available
    
    
    
78. KOBUNAI T, Matsuoka K, Takechi T
    ChIP-seq Analysis to Explore DNA Replication Profile in Trifluridine-treated Human Colorectal Cancer Cells In Vitro.
    Anticancer Res. 2019;39:3565-3570.
    PubMed     Text format     Abstract available
    
    
    
79. PARK JH, Zhao M, Oshiro H, Miyake K, et al
    Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively via Red Fluorescent Protein Labeled Stromal Cells.
    Anticancer Res. 2019;39:3463-3467.
    PubMed     Text format     Abstract available
    
    
    
80. VUJIC J, Schollnast H, Marsoner K, Wienerroither V, et al
    Marking Disappearing Colorectal Liver Metastases After Complete Response to Neoadjuvant Chemotherapy via CT - A Pilot Study.
    Anticancer Res. 2019;39:3847-3854.
    PubMed     Text format     Abstract available
    
    
    
81. PATTAYIL L, Balakrishnan-Saraswathi HT
    In Vitro Evaluation of Apoptotic Induction of Butyric Acid Derivatives in Colorectal Carcinoma Cells.
    Anticancer Res. 2019;39:3795-3801.
    PubMed     Text format     Abstract available
    
    
    June 2019
82. ETO S, Kawahara H, Matsumoto T, Hirabayashi T, et al
    Preoperative Neutrophil-Lymphocyte Ratio Is a Predictor of Bowel Obstruction Due to Colorectal Cancer Growth.
    Anticancer Res. 2019;39:3185-3189.
    PubMed     Text format     Abstract available
    
    
    
83. VIRGILIO E, Balducci G, Mercantini P, Ferri M, et al
    Curative and Prophylactic Surgery of Young-onset Colorectal Cancer in Inherited Syndromes: A 15-Year Monocentric Retrospective Experience.
    Anticancer Res. 2019;39:3131-3136.
    PubMed     Text format     Abstract available
    
    
    
84. MOKKARALA M, Noda C, Malone C, Ramaswamy R, et al
    Comparison of Response and Outcomes of Drug-eluting Bead Chemoembolization (DEB-TACE) Versus Radioembolization (TARE) for Patients With Colorectal Cancer Liver Metastases.
    Anticancer Res. 2019;39:3071-3077.
    PubMed     Text format     Abstract available
    
    
    
85. RYU S, Suwa K, Kitagawa T, Aizawa M, et al
    Real-Time Fluorescence Vessel Navigation Using Indocyanine Green During Laparoscopic Colorectal Cancer Surgery.
    Anticancer Res. 2019;39:3009-3013.
    PubMed     Text format     Abstract available
    
    
    
86. ISHIKAWA D, Takasu C, Kashihara H, Nishi M, et al
    The Significance of MicroRNA-449a and Its Potential Target HDAC1 in Patients With Colorectal Cancer.
    Anticancer Res. 2019;39:2855-2860.
    PubMed     Text format     Abstract available
    
    
    
87. WU MH, Hung YW, Gong CL, Chao CC, et al
    Contribution of Caspase-8 Genotypes to Colorectal Cancer Risk in Taiwan.
    Anticancer Res. 2019;39:2791-2797.
    PubMed     Text format     Abstract available
    
    
    
88. GZIL A, Szylberg L, Jaworski D, Dominiak J, et al
    The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
    Anticancer Res. 2019;39:2689-2697.
    PubMed     Text format     Abstract available
    
    
    
89. JUNGINGER T, Goenner U, Trinh TT, Heintz A, et al
    The Link Between Local Recurrence and Distant Metastases in Patients With Rectal Cancer.
    Anticancer Res. 2019;39:3079-3088.
    PubMed     Text format     Abstract available
    
    
    
90. TAKEDA M, Kawahara H, Ogawa M, Suwa K, et al
    Reevaluation of Preoperative Chemoradiotherapy for Clinical T3 Lower Rectal Cancer: A Multicenter Collaborative Retrospective Clinical Study.
    Anticancer Res. 2019;39:3047-3052.
    PubMed     Text format     Abstract available
    
    
    
91. PALUMBO P, Usai S, Pansa A, Lucchese S, et al
    Anastomotic Leakage in Rectal Surgery: Role of the Ghost Ileostomy.
    Anticancer Res. 2019;39:2975-2983.
    PubMed     Text format     Abstract available
    
    
    
92. YOON G, Park JY, Kim HJ, Choi GS, et al
    ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Anticancer Res. 2019;39:2845-2853.
    PubMed     Text format     Abstract available
    
    
    
93. TANIYAMA D, Taniyama K, Kuraoka K, Yamamoto H, et al
    CD204-Positive Tumor-associated Macrophages Relate to Malignant Transformation of Colorectal Adenoma.
    Anticancer Res. 2019;39:2767-2775.
    PubMed     Text format     Abstract available
    
    
    May 2019
94. RADES D, Hansen HC, Janssen S, Schild SE, et al
    Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer.
    Anticancer Res. 2019;39:2569-2574.
    PubMed     Text format     Abstract available
    
    
    
95. OGAWA H, Kaira K, Motegi Y, Yokobori T, et al
    Role of Amino Acid Transporter Expression as a Prognostic Marker in Patients With Surgically Resected Colorectal Cancer.
    Anticancer Res. 2019;39:2535-2543.
    PubMed     Text format     Abstract available
    
    
    
96. ANGELOU A, Antoniou E, Pikouli A, Wang J, et al
    Platelet Depletion/Transfusion as a Lethal Factor in a Colitis-associated Cancer Mouse Model.
    Anticancer Res. 2019;39:2443-2446.
    PubMed     Text format     Abstract available
    
    
    
97. MANTSO T, Vasileiadis S, Lampri E, Botaitis S, et al
    Hyperthermia Suppresses Post - In Vitro Proliferation and Tumor Growth in Murine Malignant Melanoma and Colon Carcinoma.
    Anticancer Res. 2019;39:2307-2315.
    PubMed     Text format     Abstract available
    
    
    April 2019
98. RALLIS G, Koletsa T, Saridaki Z, Manousou K, et al
    Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer.
    Anticancer Res. 2019;39:2129-2138.
    PubMed     Text format     Abstract available
    
    
    
99. HAMADA K, Otsubo R, Takeshita H, Nonaka T, et al
    Diagnosis of Lymph Node Metastasis in Colorectal Cancer by a Semi-dry Dot-blot Method.
    Anticancer Res. 2019;39:2069-2076.
    PubMed     Text format     Abstract available
    
    
    
100. BENDARDAF R, Sharif-Askari FS, Sharif-Askari NS, Syrjanen K, et al
     Cytoplasmic E-Cadherin Expression Is Associated With Higher Tumour Level of VEGFA, Lower Response Rate to Irinotecan-based Treatment and Poorer Prognosis in Patients With Metastatic Colorectal Cancer.
     Anticancer Res. 2019;39:1953-1957.
     PubMed     Text format     Abstract available
     
     
     
101. ALAGARATNAM S, Yang SY, Loizidou M, Fuller B, et al
     Mechano-growth Factor Expression in Colorectal Cancer Investigated With Fluorescent Gold Nanoparticles.
     Anticancer Res. 2019;39:1705-1710.
     PubMed     Text format     Abstract available
     
     
     
102. FRANSGAARD T, Hallas J, Thygesen LC, Gogenur I, et al
     Association of Statin Use and Oncological Outcomes After Neoadjuvant Radiotherapy in Patients With Rectal Cancer.
     Anticancer Res. 2019;39:2177-2182.
     PubMed     Text format     Abstract available
     
     
     
103. PETRUCCIANI N, Carra MC, Martinez-Perez A, Vitali GC, et al
     Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy.
     Anticancer Res. 2019;39:2113-2120.
     PubMed     Text format     Abstract available
     
     
     
104. SADAHIRO S, Suzuki T, Tanaka A, Okada K, et al
     Induction of CD3+ and FoxP3+ T Cells in Left-sided Colorectal Tumors After UFT/LV Chemotherapy.
     Anticancer Res. 2019;39:1997-2005.
     PubMed     Text format     Abstract available
     
     
     
105. PINELLI A, Ferrario P, Trivulzio S
     Preliminary Observation on the Cytotoxic Activity of New Chlorophyllin Derivative RCD on Human Tumour Cell Lines In Vitro.
     Anticancer Res. 2019;39:1807-1812.
     PubMed     Text format     Abstract available
     
     
     
106. OSMAN J, Bellamkonda K, Liu Q, Andersson T, et al
     The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer.
     Anticancer Res. 2019;39:1719-1728.
     PubMed     Text format     Abstract available
     
     
     March 2019
107. ARAKAWA K, Hata K, Nozawa H, Kawai K, et al
     Molecular Subtypes Are Frequently Discordant Between Lesions in Patients With Synchronous Colorectal Cancer: Molecular Analysis of 59 Patients.
     Anticancer Res. 2019;39:1425-1432.
     PubMed     Text format     Abstract available
     
     
     
108. NAGATA T, Fukuda KI, Tamai M, Taniguchi A, et al
     Early Neuropathy Related to Oxaliplatin Treatment in Advanced and Recurrent Colorectal Cancer.
     Anticancer Res. 2019;39:1347-1353.
     PubMed     Text format     Abstract available
     
     
     
109. YANO Y, Yoshimatsu K, Yokomizo H, Sagawa M, et al
     Enhancement of the Marginal Area in Colorectal Cancer Liver Metastasis on Computed Tomography Correlates With Microvessel Density and Clinicopathological Factors.
     Anticancer Res. 2019;39:1301-1308.
     PubMed     Text format     Abstract available
     
     
     
110. LI CC, Liang JA, Chung CY, Chen WT, et al
     Effectiveness of Intensity-Modulated Radiotherapy for Rectal Cancer Patients Treated With Neoadjuvant Concurrent Chemoradiotherapy: A Population-based Propensity Score-matched Analysis.
     Anticancer Res. 2019;39:1479-1484.
     PubMed     Text format     Abstract available
     
     
     
111. HANSEN HC, Janssen S, Thieme C, Perlov A, et al
     Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses.
     Anticancer Res. 2019;39:1343-1346.
     PubMed     Text format     Abstract available
     
     
     
112. REZNICZEK GA, Grunwald C, Hilal Z, Scheich J, et al
     ROBO1 Expression in Metastasizing Breast and Ovarian Cancer: SLIT2-induced Chemotaxis Requires Heparan Sulfates (Heparin).
     Anticancer Res. 2019;39:1267-1273.
     PubMed     Text format     Abstract available
     
     
     February 2019
113. YAMAMOTO M, Saito H, Uejima C, Tanio A, et al
     Combination of Serum Albumin and Cholinesterase Levels as Prognostic Indicator in Patients ith Colorectal Cancer.
     Anticancer Res. 2019;39:1085-1090.
     PubMed     Text format     Abstract available
     
     
     
114. SHIBUTANI M, Nagahara H, Fukuoka T, Iseki Y, et al
     Prognostic Significance of the C-Reactive Protein-to-Albumin Ratio in Patients With Metastatic Colorectal Cancer Treated With Trifluridine/Thymidine Phosphorylase Inhibitor as Later-line Chemotherapy.
     Anticancer Res. 2019;39:1051-1057.
     PubMed     Text format     Abstract available
     
     
     
115. KIMURA M, Usami E, Teramachi H, Yoshimura T, et al
     Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal Cancer.
     Anticancer Res. 2019;39:1029-1034.
     PubMed     Text format     Abstract available
     
     
     
116. SMOLLE MA, Kashofer K, Riedl JM, Stotz M, et al
     Genetic Analysis Using a Gene Panel in 87 Caucasian Patients With Colorectal Cancer: Own Results and Review of Literature.
     Anticancer Res. 2019;39:847-852.
     PubMed     Text format     Abstract available
     
     
     
117. SRODA-POMIANEK K, Michalak K, Palko-Labuz A, Uryga A, et al
     Simvastatin Strongly Augments Proapoptotic, Anti-inflammatory and Cytotoxic Activity of Oxicam Derivatives in Doxorubicin-resistant Colon Cancer Cells.
     Anticancer Res. 2019;39:727-734.
     PubMed     Text format     Abstract available
     
     
     
118. BAE GE, DO SI, Kim K, Park JH, et al
     Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer.
     Anticancer Res. 2019;39:663-670.
     PubMed     Text format     Abstract available
     
     
     
119. LEE D, Matsuda T, Yamashita K, Hasegawa H, et al
     Significance of Lateral Pelvic Lymph Node Size in Predicting Metastasis and Prognosis in Rectal Cancer.
     Anticancer Res. 2019;39:993-998.
     PubMed     Text format     Abstract available
     
     
     
120. RUBIO CA, Schmidt PT
     Crypts With Corrupted Shapes in Non-polypoid Adenomas.
     Anticancer Res. 2019;39:833-838.
     PubMed     Text format     Abstract available
     
     
     
121. OZTOP S, Isik A, Guner G, Gurdal H, et al
     Class III beta-tubulin Expression in Colorectal Neoplasms Is a Potential Predictive Biomarker for Paclitaxel Response.
     Anticancer Res. 2019;39:655-662.
     PubMed     Text format     Abstract available
     
     
     January 2019
122. KEARNEY MR, Chen EY, Vaccaro GM, Strother J, et al
     A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer.
     Anticancer Res. 2019;39:245-252.
     PubMed     Text format     Abstract available
     
     
     
123. SHIMIZU D, Masuda T, Sato K, Tsuruda Y, et al
     CRMP5-associated GTPase (CRAG) Is a Candidate Driver Gene for Colorectal Cancer Carcinogenesis.
     Anticancer Res. 2019;39:99-106.
     PubMed     Text format     Abstract available
     
     
     
124. KUDOU M, Arita T, Nakanishi M, Kuriu Y, et al
     Essentiality of Imaging Diagnostic Criteria Specific to Rectal Neuroendocrine Tumors for Detecting Metastatic Lymph Nodes.
     Anticancer Res. 2019;39:505-510.
     PubMed     Text format     Abstract available
     
     
     
125. GUIMARAES DP, Fregnani JH, Reis RM, Taveira LN, et al
     Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
     Anticancer Res. 2019;39:261-269.
     PubMed     Text format     Abstract available
     
     
     
126. WAKUI M, Kawai K, Mizushima T, Nishime C, et al
     Fatty Acid beta-Oxidation-dependent and -independent Responses and Tumor Aggressiveness Acquired Under Mild Hypoxia.
     Anticancer Res. 2019;39:191-200.
     PubMed     Text format     Abstract available
     
     
     
127. MUTO Y, Furihata T, Kaneko M, Higuchi K, et al
     Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203.
     Anticancer Res. 2019;39:159-165.
     PubMed     Text format     Abstract available
     
     
     
128. GUDUR A, Shanmuganandamurthy D, Szep Z, Poggio JL, et al
     An Update on the Current Role of High Resolution Anoscopy in Patients With Anal Dysplasia.
     Anticancer Res. 2019;39:17-23.
     PubMed     Text format     Abstract available
     
     
     December 2018
129. SHIBUYA N, Ishizuka M, Takagi K, Iwasaki Y, et al
     Relationship Between Preoperative Erythrocyte Sedimentation Rate and Survival After Surgery in Patients with Colorectal Cancer.
     Anticancer Res. 2018;38:6783-6788.
     PubMed     Text format     Abstract available
     
     
     
130. MATSUTANI S, Shibutani M, Maeda K, Nagahara H, et al
     Tumor-infiltrating Immune Cells in H&E-stained Sections of Colorectal Cancer Tissue as a Reasonable Immunological Biomarker.
     Anticancer Res. 2018;38:6721-6727.
     PubMed     Text format     Abstract available
     
     
     
131. KOH HK, Kim K, Jang WI, Song CH, et al
     Radiation Therapy for Anal Squamous Cell Carcinoma: A Retrospective Multicenter Study.
     Anticancer Res. 2018;38:6931-6938.
     PubMed     Text format     Abstract available
     
     
     
132. LEE JH, Song C, Kang SB, Lee HS, et al
     Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
     Anticancer Res. 2018;38:6905-6910.
     PubMed     Text format     Abstract available
     
     
     
133. KIM J, Ahn S, Kim K, Cho MS, et al
     Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial-Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy.
     Anticancer Res. 2018;38:6881-6889.
     PubMed     Text format     Abstract available
     
     
     
134. RADES D, Vogelsang RP, Treder M, Janssen S, et al
     A Matched-Pair Study Comparing Surgery Plus Neoadjuvant Radio-Chemotherapy and Surgery Alone for High Rectal Cancers.
     Anticancer Res. 2018;38:6877-6880.
     PubMed     Text format     Abstract available
     
     
     
135. MORELLI C, Formica V, Pellicori S, Menghi A, et al
     Chemotherapy in Patients with Hereditary Angioedema.
     Anticancer Res. 2018;38:6801-6807.
     PubMed     Text format     Abstract available
     
     
     November 2018
136. BENDARDAF R, Sharif-Askari FS, Sharif-Askari NS, Syrjanen K, et al
     Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen.
     Anticancer Res. 2018;38:6399-6404.
     PubMed     Text format     Abstract available
     
     
     
137. MASUDA T, Margonis GA, Andreatos N, Wang J, et al
     Combined Hepatic Resection and Radio-frequency Ablation for Patients with Colorectal Cancer Liver Metastasis: A Viable Option for Patients with a Large Number of Tumors.
     Anticancer Res. 2018;38:6353-6360.
     PubMed     Text format     Abstract available
     
     
     
138. ENKHBAT T, Nishi M, Yoshikawa K, Jun H, et al
     Epigallocatechin-3-gallate Enhances Radiation Sensitivity in Colorectal Cancer Cells Through Nrf2 Activation and Autophagy.
     Anticancer Res. 2018;38:6247-6252.
     PubMed     Text format     Abstract available
     
     
     
139. DA SILVA MACHADO F, Munari FM, Scariot FJ, Echeverrigaray S, et al
     Piperlongumine Induces Apoptosis in Colorectal Cancer HCT 116 Cells Independent of Bax, p21 and p53 Status.
     Anticancer Res. 2018;38:6231-6236.
     PubMed     Text format     Abstract available
     
     
     
140. SUEHIRO Y, Takemoto Y, Nishimoto A, Ueno K, et al
     Dclk1 Inhibition Cancels 5-FU-induced Cell-cycle Arrest and Decreases Cell Survival in Colorectal Cancer.
     Anticancer Res. 2018;38:6225-6230.
     PubMed     Text format     Abstract available
     
     
     
141. SEMAAN C, Neilson KA, Brown B, Molloy MP, et al
     Pharmacological Inhibition of Casein Kinase 2 Enhances the Effectiveness of PI3K Inhibition in Colon Cancer Cells.
     Anticancer Res. 2018;38:6195-6200.
     PubMed     Text format     Abstract available
     
     
     
142. NAKURTE I, Jekabsons K, Rembergs R, Zandberga E, et al
     Colorectal Cancer Cell Line SW480 and SW620 Released Extravascular Vesicles: Focus on Hypoxia-induced Surface Proteome Changes.
     Anticancer Res. 2018;38:6133-6138.
     PubMed     Text format     Abstract available
     
     
     
143. WANG B, Ogata H, Takishima Y, Miyamoto S, et al
     A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer Using Oxaliplatin and Coxsackievirus A11.
     Anticancer Res. 2018;38:6121-6126.
     PubMed     Text format     Abstract available
     
     
     
144. MASUISHI T, Taniguchi H, Eto T, Komori A, et al
     Morphologic Response and Tumor Shrinkage as Early Predictive Markers in Unresectable Colorectal Liver Metastases.
     Anticancer Res. 2018;38:6501-6506.
     PubMed     Text format     Abstract available
     
     
     
145. PALKOVICS A, Vereczkei A, Kalmar KN, Fincsur A, et al
     The Issue of Survival After Colorectal Liver Metastasis Surgery: Parenchyma Sparing vs. Radicality.
     Anticancer Res. 2018;38:6431-6438.
     PubMed     Text format     Abstract available
     
     
     October 2018
146. KAMIZA AB, Wang WC, You JF, Tang R, et al
     EGFR, SMAD7, and TGFBR2 Polymorphisms Are Associated with Colorectal Cancer in Patients with Lynch Syndrome.
     Anticancer Res. 2018;38:5983-5990.
     PubMed     Text format     Abstract available
     
     
     
147. ARAKAWA K, Hata K, Nozawa H, Kawai K, et al
     Prognostic Significance and Clinicopathological Features of Synchronous Colorectal Cancer.
     Anticancer Res. 2018;38:5889-5895.
     PubMed     Text format     Abstract available
     
     
     
148. KIM JN, Kim TH, Yoon JH, Cho SG, et al
     Kisspeptin Inhibits Colorectal Cancer Cell Invasiveness by Activating PKR and PP2A.
     Anticancer Res. 2018;38:5791-5798.
     PubMed     Text format     Abstract available
     
     
     
149. SINGH B, Singh G, Pourgholami M, Alzahrani N, et al
     Long-term Survival and Propensity Score Matched Outcomes of Bilateral vs. Unilateral Diaphragm Interventions in Cytoreductive Surgery plus Intra-peritoneal Chemotherapy.
     Anticancer Res. 2018;38:5917-5921.
     PubMed     Text format     Abstract available
     
     
     
150. MURATA H, Okamoto M, Takahashi T, Motegi M, et al
     SUVmax-based Parameters of FDG-PET/CT Reliably Predict Pathologic Complete Response After Preoperative Hyperthermo-chemoradiotherapy in Rectal Cancer.
     Anticancer Res. 2018;38:5909-5916.
     PubMed     Text format     Abstract available
     
     
     
151. DE CESARE M
     High Efficacy of Intravenous Gimatecan on Human Tumor Xenografts.
     Anticancer Res. 2018;38:5783-5790.
     PubMed     Text format     Abstract available
     
     
     
152. AKAMINE T, Morodomi Y, Harada Y, Teraishi K, et al
     miR-3148 Is a Novel Onco-microRNA that Potentiates Tumor Growth In Vivo.
     Anticancer Res. 2018;38:5693-5701.
     PubMed     Text format     Abstract available
     
     
     September 2018
153. JORDAN F, Grundmann N, Schenkirsch G, Markl B, et al
     Impact of Primary Tumor Localization on the Efficacy of Bevacizumab in Metastatic Colorectal Cancer.
     Anticancer Res. 2018;38:5539-5546.
     PubMed     Text format     Abstract available
     
     
     
154. KAWAHARA H, Yoshida S, Tohyama Y, Yanagisawa S, et al
     Serum Carcinoembryonic Antigen Levels Before the First Curative Hepatectomy for Metastatic Colorectal Cancer Is a Predictor of Recurrence.
     Anticancer Res. 2018;38:5351-5355.
     PubMed     Text format     Abstract available
     
     
     
155. ENDZELINS E, Abols A, Buss A, Zandberga E, et al
     Extracellular Vesicles Derived from Hypoxic Colorectal Cancer Cells Confer Metastatic Phenotype to Non-metastatic Cancer Cells.
     Anticancer Res. 2018;38:5139-5147.
     PubMed     Text format     Abstract available
     
     
     
156. LEA MA, Kim H, desBORDES C
     Effects of Biguanides on Growth and Glycolysis of Bladder and Colon Cancer Cells.
     Anticancer Res. 2018;38:5003-5011.
     PubMed     Text format     Abstract available
     
     
     
157. TRESKA V, Fichtl J, Ludvik J, Bruha J, et al
     Portal Vein Embolization (PVE) Versus PVE with Haematopoietic Stem Cell Application in Patients with Primarily Non-resectable Colorectal Liver Metastases.
     Anticancer Res. 2018;38:5531-5537.
     PubMed     Text format     Abstract available
     
     
     
158. PARK CK, Kim HS
     Clinicopathological Characteristics of Ovarian Metastasis from Colorectal and Pancreatobiliary Carcinomas Mimicking Primary Ovarian Mucinous Tumor.
     Anticancer Res. 2018;38:5465-5473.
     PubMed     Text format     Abstract available
     
     
     
159. HEINZE C, Omari J, Othmer M, Hass P, et al
     Image-guided Interstitial Brachytherapy in the Management of Metastasized Anal Squamous Cell Carcinoma.
     Anticancer Res. 2018;38:5401-5407.
     PubMed     Text format     Abstract available
     
     
     
160. TREDER M, Janssen S, Hollander NH, Schild SE, et al
     Role of Neoadjuvant Radio-chemotherapy for the Treatment of High Rectal Cancer.
     Anticancer Res. 2018;38:5371-5377.
     PubMed     Text format     Abstract available
     
     
     
161. RUBIO CA, Schmidt PT
     Are Non-dysplastic Crypts with Corrupted Shapes the Initial Recordable Histological Event in the Development of Sporadic Conventional Adenomas?
     Anticancer Res. 2018;38:5315-5320.
     PubMed     Text format     Abstract available
     
     
     August 2018
162. DAITOKU N, Miyamoto Y, Tokunaga R, Sakamoto Y, et al
     Controlling Nutritional Status (CONUT) Score Is a Prognostic Marker in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy.
     Anticancer Res. 2018;38:4883-4888.
     PubMed     Text format     Abstract available
     
     
     
163. ARAKAWA K, Hata K, Kawai K, Tanaka T, et al
     Predictors for High Microsatellite Instability in Patients with Colorectal Cancer Fulfilling the Revised Bethesda Guidelines.
     Anticancer Res. 2018;38:4871-4876.
     PubMed     Text format     Abstract available
     
     
     
164. HIRAYAMA K, Sudoh M, Shimizu H, Furuya S, et al
     Clinical Impact of Histological Heterogeneity in the Metastatic Lymph Nodes of Patients with Colorectal Cancer.
     Anticancer Res. 2018;38:4797-4803.
     PubMed     Text format     Abstract available
     
     
     
165. KARLBERG M, Stenstedt K, Hallstrom M, Ragnhammar P, et al
     Tumor Budding Versus Mismatch Repair Status in Colorectal Cancer - An Exploratory Analysis.
     Anticancer Res. 2018;38:4713-4721.
     PubMed     Text format     Abstract available
     
     
     
166. SIM JJ, Park MH, Baek JH, Lee H, et al
     Investigation into Enhancing Capecitabine Efficacy in Colorectal Cancer by Inhibiting Focal Adhesion Kinase Signaling.
     Anticancer Res. 2018;38:4667-4676.
     PubMed     Text format     Abstract available
     
     
     
167. LIU W, Zhang D, Tan SA, Liu X, et al
     Sigmoid Colon Adenocarcinoma with Isolated Loss of PMS2 Presenting in a Patient with Synchronous Prostate Cancer with Intact MMR: Diagnosis and Analysis of the Family Pedigree.
     Anticancer Res. 2018;38:4847-4852.
     PubMed     Text format     Abstract available
     
     
     
168. LEE YM, Yeo MK, Seong IO, Kim KH, et al
     Nuclear Expression of CD133 Is Associated with Good Prognosis in Patients with Colorectal Adenocarcinoma.
     Anticancer Res. 2018;38:4819-4826.
     PubMed     Text format     Abstract available
     
     
     
169. MIYAKITA H, Sadahiro S, Kamei Y, Ogimi T, et al
     Chemoradiotherapy-induced Changes in Mucinous Components in Rectal Cancer Tissue: Evaluation on High Iron Diamine-alcian Blue and Mucin 1 Staining.
     Anticancer Res. 2018;38:4783-4787.
     PubMed     Text format     Abstract available
     
     
     
170. TUTINO V, DE Nunzio V, Tafaro A, Bianco G, et al
     Cannabinoid Receptor-1 Up-regulation in Azoxymethane (AOM)-treated Mice After Dietary Treatment with Quercetin.
     Anticancer Res. 2018;38:4485-4491.
     PubMed     Text format     Abstract available
     
     
     
171. NAKAMURA M, Suetsugu A, Hasegawa K, Satake T, et al
     Color-coded Imaging Distinguishes Cancer Cells, Stromal Cells, and Recombinant Cancer-stromal Cells in the Tumor Microenvironment During Metastasis.
     Anticancer Res. 2018;38:4417-4423.
     PubMed     Text format     Abstract available
     
     
     July 2018
172. YOSHIDA Y, Sakamoto R, Kajitani R, Munechika T, et al
     Biweekly Administration of TAS-102 for Neutropenia Prevention in Patients with Colorectal Cancer.
     Anticancer Res. 2018;38:4367-4373.
     PubMed     Text format     Abstract available
     
     
     
173. LUO H, Nishi K, Ishikura S, Swain A, et al
     Growth Suppression of Human Colorectal Cancer Cells with Mutated KRAS by 3-Deaza-cytarabine in 3D Floating Culture.
     Anticancer Res. 2018;38:4247-4256.
     PubMed     Text format     Abstract available
     
     
     
174. YUN CW, Kim S, Lee JH, Lee SH, et al
     Melatonin Promotes Apoptosis of Colorectal Cancer Cells via Superoxide-mediated ER Stress by Inhibiting Cellular Prion Protein Expression.
     Anticancer Res. 2018;38:3951-3960.
     PubMed     Text format     Abstract available
     
     
     
175. CHABOWSKI M, Nowak A, Grzegrzolka J, Piotrowska A, et al
     Comparison of Microvessel Density Using Nestin and CD34 in Colorectal Cancer.
     Anticancer Res. 2018;38:3889-3895.
     PubMed     Text format     Abstract available
     
     
     
176. RUBIO CA, Schmidt PT
     Severe Defects in the Macrophage Barrier to Gut Microflora in Inflammatory Bowel Disease and Colon Cancer.
     Anticancer Res. 2018;38:3811-3815.
     PubMed     Text format     Abstract available
     
     
     
177. MAEDA K, Shibutani M, Otani H, Fukuoka T, et al
     Neoadjuvant Radiotherapy with Capecitabine Plus Bevacizumab for Locally Advanced Lower Rectal Cancer: Results of a Single-institute Phase II Study.
     Anticancer Res. 2018;38:4193-4197.
     PubMed     Text format     Abstract available
     
     
     
178. VYCITAL O, Dubova M, Palek R, Hosek P, et al
     The Impact of Immune Interaction on the Metastatic Infiltration of Colorectal Carcinoma to Lymph Nodes.
     Anticancer Res. 2018;38:4159-4167.
     PubMed     Text format     Abstract available
     
     
     
179. TUPY R, Mirka H, Mracek J, Priban V, et al
     Tumor-related Perfusion Changes in White Matter Adjacent to Brain Tumors: Pharmacodynamic Analysis of Dynamic 3T Magnetic Resonance Imaging.
     Anticancer Res. 2018;38:4149-4152.
     PubMed     Text format     Abstract available
     
     
     
180. KIM S, Park SG, Song YJ, Park JK, et al
     Analysis of Anticancer Activity and Chemical Sensitization Effects of Dendropanax morbifera and Commersonia bartramia Extracts.
     Anticancer Res. 2018;38:3853-3861.
     PubMed     Text format     Abstract available
     
     
     June 2018
181. SAWAZAKI S, Numata M, Morita J, Maezawa Y, et al
     Safety of Laparoscopic Surgery for Colorectal Cancer in Patients with Severe Comorbidities.
     Anticancer Res. 2018;38:3767-3772.
     PubMed     Text format     Abstract available
     
     
     
182. VENALAINEN MK, Roine AN, Hakkinen MR, Vepsalainen JJ, et al
     Altered Polyamine Profiles in Colorectal Cancer.
     Anticancer Res. 2018;38:3601-3607.
     PubMed     Text format     Abstract available
     
     
     
183. ENKHBAT T, Nishi M, Takasu C, Yoshikawa K, et al
     Programmed Cell Death Ligand 1 Expression Is an Independent Prognostic Factor in Colorectal Cancer.
     Anticancer Res. 2018;38:3367-3373.
     PubMed     Text format     Abstract available
     
     
     
184. OKUNO T, Kawai K, Hata K, Murono K, et al
     SN-38 Acts as a Radiosensitizer for Colorectal Cancer by Inhibiting the Radiation-induced Up-regulation of HIF-1alpha.
     Anticancer Res. 2018;38:3323-3331.
     PubMed     Text format     Abstract available
     
     
     
185. ANGELOU A, Andreatos N, Antoniou E, Zacharioudaki A, et al
     A Novel Modification of the AOM/DSS Model for Inducing Intestinal Adenomas in Mice.
     Anticancer Res. 2018;38:3467-3470.
     PubMed     Text format     Abstract available
     
     
     
186. LING G, Lamprecht S, Shubinsky G, Osyntsov L, et al
     Mycophenolate Mofetil Alone and in Combination with Tacrolimus Inhibits the Proliferation of HT-29 Human Colonic Adenocarcinoma Cell Line and Might Interfere with Colonic Tumorigenesis.
     Anticancer Res. 2018;38:3333-3339.
     PubMed     Text format     Abstract available
     
     
     May 2018
187. RADES D, Dziggel L, Blanck O, Gebauer N, et al
     A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy.
     Anticancer Res. 2018;38:3111-3114.
     PubMed     Text format     Abstract available
     
     
     
188. TEI M, Otsuka M, Suzuki Y, Kishi K, et al
     Safety and Feasibility of Single-port Surgery for Colon Cancer in Octogenarians.
     Anticancer Res. 2018;38:2967-2972.
     PubMed     Text format     Abstract available
     
     
     
189. PATANKAR M, Vayrynen S, Tuomisto A, Makinen M, et al
     Micropapillary Structures in Colorectal Cancer: An Anoikis-resistant Subpopulation.
     Anticancer Res. 2018;38:2915-2921.
     PubMed     Text format     Abstract available
     
     
     
190. DESHWAR A, Margonis GA, Andreatos N, Barbon C, et al
     Double KRAS and BRAF Mutations in Surgically Treated Colorectal Cancer Liver Metastases: An International, Multi-institutional Case Series.
     Anticancer Res. 2018;38:2891-2895.
     PubMed     Text format     Abstract available
     
     
     
191. CACEV T, Zapletal E, Musani V, Rako I, et al
     Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancer.
     Anticancer Res. 2018;38:2841-2848.
     PubMed     Text format     Abstract available
     
     
     
192. TUTINO V, Defrancesco ML, Tolomeo M, DE Nunzio V, et al
     The Expression of Riboflavin Transporters in Human Colorectal Cancer.
     Anticancer Res. 2018;38:2659-2667.
     PubMed     Text format     Abstract available
     
     
     
193. CLOUSTON HW, Rees PA, Lamb R, Duff SE, et al
     Effect of Tissue Factor on Colorectal Cancer Stem Cells.
     Anticancer Res. 2018;38:2635-2642.
     PubMed     Text format     Abstract available
     
     
     
194. ALFONSO PG, Podesta MC, Martin AM, Codeisido MB, et al
     Chemotherapy Plus Bevacizumab as Neoadjuvant or Conversion Treatment in Patients with Colorectal Liver Metastases.
     Anticancer Res. 2018;38:3069-3077.
     PubMed     Text format     Abstract available
     
     
     
195. CUSHMAN TR, Venigalla S, Brooks ED, Lin C, et al
     Utilization of Neoadjuvant Intensity-modulated Radiation Therapy for Rectal Cancer in the United States.
     Anticancer Res. 2018;38:2923-2927.
     PubMed     Text format     Abstract available
     
     
     
196. JOO JW, Kim HS, Do SI, Sung JY, et al
     Expression of Zinc Finger and BTB Domain-containing 7A in Colorectal Carcinoma.
     Anticancer Res. 2018;38:2787-2792.
     PubMed     Text format     Abstract available
     
     
     April 2018
197. KAWAHARA H, Mouri T, Ishida K, Matsumoto N, et al
     Usefulness of TAS-102 as Third-line Chemotherapy for Metastatic Colorectal Cancer.
     Anticancer Res. 2018;38:2419-2422.
     PubMed     Text format     Abstract available
     
     
     
198. ISEKI Y, Shibutani M, Maeda K, Nagahara H, et al
     MicroRNA-96 Promotes Tumor Invasion in Colorectal Cancer via RECK.
     Anticancer Res. 2018;38:2031-2035.
     PubMed     Text format     Abstract available
     
     
     
199. LIN KM, Yang MD, Tsai CW, Chang WS, et al
     The Role of MTHFR Genotype in Colorectal Cancer Susceptibility in Taiwan.
     Anticancer Res. 2018;38:2001-2006.
     PubMed     Text format     Abstract available
     
     
     
200. LEE JH, Yoon YM, Han YS, Yun CW, et al
     Melatonin Promotes Apoptosis of Oxaliplatin-resistant Colorectal Cancer Cells Through Inhibition of Cellular Prion Protein.
     Anticancer Res. 2018;38:1993-2000.
     PubMed     Text format     Abstract available
     
     
     
201. WANG W, Li Y, Chen Y, Chen H, et al
     Ethanolic Extract of Traditional Chinese Medicine (TCM) Gamboge Inhibits Colon Cancer via the Wnt/Beta-Catenin Signaling Pathway in an Orthotopic Mouse Model.
     Anticancer Res. 2018;38:1917-1925.
     PubMed     Text format     Abstract available
     
     
     
202. RUBIO CA, Schmidt PT
     Morphological Classification of Corrupted Colonic Crypts in Ulcerative Colitis.
     Anticancer Res. 2018;38:2253-2259.
     PubMed     Text format     Abstract available
     
     
     
203. SIDERIS M, Donaldson AN, Hanrahan J, Grunwald M, et al
     Radiotherapy May Offer a Recurrence and Survival Benefit in Rectal Cancers Treated Surgically with Transanal Endoscopic Microsurgery: A Systematic Review and Meta-analysis.
     Anticancer Res. 2018;38:1879-1895.
     PubMed     Text format     Abstract available
     
     
     March 2018
204. ETO K, Kosuge M, Ohkuma M, Noaki R, et al
     Defunctioning Ileostomy Is a Key Risk Factor for Small Bowel Obstruction After Colorectal Cancer Resection.
     Anticancer Res. 2018;38:1789-1795.
     PubMed     Text format     Abstract available
     
     
     
205. FURUKE H, Komatsu S, Ikeda J, Tanaka S, et al
     Self-expandable Metallic Stents Contribute to Reducing Perioperative Complications in Colorectal Cancer Patients with Acute Obstruction.
     Anticancer Res. 2018;38:1749-1753.
     PubMed     Text format     Abstract available
     
     
     
206. SUENAGA M, Akiyoshi T, Shinozaki E, Fujimoto Y, et al
     A Feasibility Study of Capecitabine and Oxaliplatin for Patients with Stage II/III Colon Cancer -ACTOR Study.
     Anticancer Res. 2018;38:1741-1747.
     PubMed     Text format     Abstract available
     
     
     
207. OKUGAWA Y, Shirai Y, Toiyama Y, Saigusa S, et al
     Clinical Burden of Modified Glasgow Prognostic Scale in Colorectal Cancer.
     Anticancer Res. 2018;38:1599-1610.
     PubMed     Text format     Abstract available
     
     
     
208. CHEN Y, Lee CH, Tseng BY, Tsai YH, et al
     AZD8055 Exerts Antitumor Effects on Colon Cancer Cells by Inhibiting mTOR and Cell-cycle Progression.
     Anticancer Res. 2018;38:1445-1454.
     PubMed     Text format     Abstract available
     
     
     
209. BABA T, Kokuryo T, Yamaguchi J, Yokoyama Y, et al
     Pre-exposure to Fluorouracil Increased Trifluridine Incorporation and Enhanced its Anti-tumor Effect for Colorectal Cancer.
     Anticancer Res. 2018;38:1427-1434.
     PubMed     Text format     Abstract available
     
     
     
210. NA K, Sung JY, Kim HS
     Clinicopathological Characteristics of High-grade Squamous Intraepithelial Lesions Involving Condyloma Acuminatum.
     Anticancer Res. 2018;38:1767-1774.
     PubMed     Text format     Abstract available
     
     
     
211. YOSHIKAWA K, Shimada M, Higashijima J, Nakao T, et al
     Ki-67 and Survivin as Predictive Factors for Rectal Cancer Treated with Preoperative Chemoradiotherapy.
     Anticancer Res. 2018;38:1735-1739.
     PubMed     Text format     Abstract available
     
     
     
212. KERR D, Laber D, Visweshwar N, Jaglal M, et al
     Case Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with Oxaliplatin.
     Anticancer Res. 2018;38:1711-1713.
     PubMed     Text format     Abstract available
     
     
     
213. LACZMANSKA I, Sasiadek M, Laczmanski L
     The Comparison Between Molecular Tumour Profiling in Microdissected and Surgical Tissue Samples.
     Anticancer Res. 2018;38:1415-1418.
     PubMed     Text format     Abstract available
     
     
     February 2018
214. SHINAGAWA T, Hata K, Morikawa T, Takiyama H, et al
     Protrusion on the Depressed Surface of Non-polypoid T1 Colorectal Cancer Is Associated with Venous Invasion.
     Anticancer Res. 2018;38:993-1002.
     PubMed     Text format     Abstract available
     
     
     
215. NUMATA M, Sawazaki S, Morita J, Maezawa Y, et al
     Comparison of Laparoscopic and Open Surgery for Colorectal Cancer in Patients with Severe Comorbidities.
     Anticancer Res. 2018;38:963-967.
     PubMed     Text format     Abstract available
     
     
     
216. KANG S, Oh SC, Min BW, Lee DH, et al
     Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
     Anticancer Res. 2018;38:787-794.
     PubMed     Text format     Abstract available
     
     
     
217. OSADA S, Gotoh A, Yokoi R, Tsuchiya H, et al
     Effective Timing of Surgical Resection of Colorectal Cancer Liver Metastases During Chemotherapy.
     Anticancer Res. 2018;38:737-743.
     PubMed     Text format     Abstract available
     
     
     
218. HAUSMANN D, Liu J, Budjan J, Reichert M, et al
     Image Quality Assessment of 2D versus 3D T2WI and Evaluation of Ultra-high b-Value (b=2,000 mm/s(2)) DWI for Response Assessment in Rectal Cancer.
     Anticancer Res. 2018;38:969-978.
     PubMed     Text format     Abstract available
     
     
     
219. RUBIO CA, DE Petris G, Puppa G
     Gut-associated Lymphoid Tissue (GALT) Carcinoma in Ulcerative Colitis.
     Anticancer Res. 2018;38:919-921.
     PubMed     Text format     Abstract available
     
     
     
220. BUNDSCHERER AC, Malsy M, Gruber MA, Graf BM, et al
     Acetaminophen and Metamizole Induce Apoptosis in HT 29 and SW 480 Colon Carcinoma Cell Lines In Vitro.
     Anticancer Res. 2018;38:745-751.
     PubMed     Text format     Abstract available
     
     
     
221. JUNG YY, Sung JY, Kim JY, Kim HS, et al
     Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in Colorectal Carcinoma.
     Anticancer Res. 2018;38:691-697.
     PubMed     Text format     Abstract available
     
     
     
222. LUNDBERG IV, Wikberg ML, Ljuslinder I, Li X, et al
     MicroRNA Expression in KRAS- and BRAF-mutated Colorectal Cancers.
     Anticancer Res. 2018;38:677-683.
     PubMed     Text format     Abstract available
     
     
     
223. CEAUSU AR, Ciolofan A, Cimpean AM, Magheti A, et al
     The Mesenchymal-Epithelial and Epithelial-Mesenchymal Cellular Plasticity of Liver Metastases with Digestive Origin.
     Anticancer Res. 2018;38:811-816.
     PubMed     Text format     Abstract available
     
     
     January 2018
224. KATSUKI T, Nakayama Y, Akiyama M, Sawatsubashi Y, et al
     Prognostic Significance of Mitochondrial Transcription Factor A Expression in Patients with Right- or Left-sided Colorectal Cancer.
     Anticancer Res. 2018;38:569-575.
     PubMed     Text format     Abstract available
     
     
     
225. TAKAHASHI H, Haraguchi N, Nishimura J, Hata T, et al
     The Severity of Anastomotic Leakage May Negatively Impact the Long-term Prognosis of Colorectal Cancer.
     Anticancer Res. 2018;38:533-539.
     PubMed     Text format     Abstract available
     
     
     
226. MIYAMOTO Y, Oki E, Emi Y, Tokunaga S, et al
     Low Visceral Fat Content Is a Negative Predictive Marker for Bevacizumab in Metastatic Colorectal Cancer.
     Anticancer Res. 2018;38:491-499.
     PubMed     Text format     Abstract available
     
     
     
227. SHAMOUN L, Kolodziej B, Andersson RE, Dimberg J, et al
     Protein Expression and Genetic Variation of IL32 and Association with Colorectal Cancer in Swedish Patients.
     Anticancer Res. 2018;38:321-328.
     PubMed     Text format     Abstract available
     
     
     
228. JO YK, Park NY, Shin JH, Jo DS, et al
     Up-regulation of UVRAG by HDAC1 Inhibition Attenuates 5FU-induced Cell Death in HCT116 Colorectal Cancer Cells.
     Anticancer Res. 2018;38:271-277.
     PubMed     Text format     Abstract available
     
     
     
229. YANG G, Qiu J, Wang D, Tao Y, et al
     Traditional Chinese Medicine Curcumin Sensitizes Human Colon Cancer to Radiation by Altering the Expression of DNA Repair-related Genes.
     Anticancer Res. 2018;38:131-136.
     PubMed     Text format     Abstract available
     
     
     
230. MURONO K, Kawai K, Hata K, Emoto S, et al
     Regimens of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer.
     Anticancer Res. 2018;38:15-22.
     PubMed     Text format     Abstract available
     
     
     
231. SPELT L, Sasor A, Ansari D, Hilmersson KS, et al
     The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
     Anticancer Res. 2018;38:313-320.
     PubMed     Text format     Abstract available
     
     
     
232. GLEI M, Fischer S, Lamberty J, Ludwig D, et al
     Chemopreventive Potential of In Vitro Fermented Raw and Roasted Hazelnuts in LT97 Colon Adenoma Cells.
     Anticancer Res. 2018;38:83-93.
     PubMed     Text format     Abstract available
     
     
     December 2017
233. LIANG YH, Shao YY, Chen HM, Cheng AL, et al
     Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study.
     Anticancer Res. 2017;37:7095-7104.
     PubMed     Text format     Abstract available
     
     
     
234. GKEKAS I, Novotny J, Pecen L, Strigard K, et al
     Microsatellite Instability as a Prognostic Factor in Stage II Colon Cancer Patients, a Meta-Analysis of Published Literature.
     Anticancer Res. 2017;37:6563-6574.
     PubMed     Text format     Abstract available
     
     
     
235. YAMAMOTO S, Kanai T, Osumi K, Yo K, et al
     Anastomotic Leakage Using Linear Stapling Device with Pre-attached Bioabsorbable Polyglycolic Acid Felt After Laparoscopic Anterior Resection.
     Anticancer Res. 2017;37:7083-7086.
     PubMed     Text format     Abstract available
     
     
     
236. MIYATA T, Beppu T, Higashi T, Nakagawa S, et al
     A Glissonean Approach with Individual Isolation During Right Hemi-Hepatectomy After Portal Vein Embolization.
     Anticancer Res. 2017;37:7069-7071.
     PubMed     Text format     Abstract available
     
     
     
237. RUBIO CA
     Updated Histologic Classification of Adenomas and Carcinomas in the Colon of Carcinogen-treated Sprague-Dawley Rats.
     Anticancer Res. 2017;37:6667-6670.
     PubMed     Text format     Abstract available
     
     
     November 2017
238. KAJITANI T, Makiyama A, Arita S, Shimokawa H, et al
     Anti-Epidermal Growth Factor Receptor Antibody Readministration in Chemorefractory Metastatic Colorectal Cancer.
     Anticancer Res. 2017;37:6459-6468.
     PubMed     Text format     Abstract available
     
     
     
239. MERCIER J, Voutsadakis IA
     A Systematic Review and Meta-analysis of Retrospective Series of Regorafenib for Treatment of Metastatic Colorectal Cancer.
     Anticancer Res. 2017;37:5925-5934.
     PubMed     Text format     Abstract available
     
     
     
240. CIRIMBEI C, Rotaru V, Chitoran E, Pavaleanu O, et al
     Immediate and Long-term Results of Radiofrequency Ablation for Colorectal Liver Metastases.
     Anticancer Res. 2017;37:6489-6494.
     PubMed     Text format     Abstract available
     
     
     October 2017
241. TAKIYAMA A, Tanaka T, Yamamoto Y, Hata K, et al
     Microsatellite Status of Primary Colorectal Cancer Predicts the Incidence of Postoperative Colorectal Neoplasms.
     Anticancer Res. 2017;37:5785-5790.
     PubMed     Text format     Abstract available
     
     
     
242. BAKALOVA R, Zhelev Z, Shibata S, Nikolova B, et al
     Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic" Versus "Onco-Suppressive" Reactive Oxygen Species.
     Anticancer Res. 2017;37:5449-5458.
     PubMed     Text format     Abstract available
     
     
     
243. TANASE T, Hamada C, Yoshino T, Ohtsu A, et al
     A Proposal for Progression-Free Survival Assessment in Patients with Early Progressive Cancer.
     Anticancer Res. 2017;37:5851-5855.
     PubMed     Text format     Abstract available
     
     
     
244. IDE S, Toiyama Y, Okugawa Y, Oki S, et al
     Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.
     Anticancer Res. 2017;37:5797-5804.
     PubMed     Text format     Abstract available
     
     
     
245. KAWAHARA H, Akiba T, Yanaga K
     Transanal Assisted Resection with Closure of Anal Canal for Lower Rectal Diseases.
     Anticancer Res. 2017;37:5767-5769.
     PubMed     Text format     Abstract available
     
     
     
246. TOKUNAGA T, Nishi M, Higashijima J, Yoshikawa K, et al
     Feasibility of Transanal Local Excision Following Chemoradiation for Lower Rectal Cancer.
     Anticancer Res. 2017;37:5617-5622.
     PubMed     Text format     Abstract available
     
     
     
247. SUNG JY, Na K, Kim HS
     Down-regulation of Inositol Polyphosphate 4-Phosphatase Type II Expression in Colorectal Carcinoma.
     Anticancer Res. 2017;37:5525-5531.
     PubMed     Text format     Abstract available
     
     
     
248. IKEMURA M, Hashida T
     Effect of Hyperglycemia on Antitumor Activity and Survival in Tumor-bearing Mice Receiving Oxaliplatin and Fluorouracil.
     Anticancer Res. 2017;37:5463-5468.
     PubMed     Text format     Abstract available
     
     
     September 2017
249. KANEKO M, Nozawa H, Emoto S, Murono K, et al
     Neoadjuvant Imatinib Therapy Followed by Intersphincteric Resection for Low Rectal Gastrointestinal Stromal Tumors.
     Anticancer Res. 2017;37:5155-5160.
     PubMed     Text format     Abstract available
     
     
     
250. ANNEDE P, Darreon J, Benkemouche A, Valdenaire S, et al
     Flattening Filter Free vs. Flattened Beams for Lung Stereotactic Body Radiation Therapy.
     Anticancer Res. 2017;37:5133-5139.
     PubMed     Text format     Abstract available
     
     
     
251. NONAKA T, Fukuda A, Maekawa K, Nagayoshi S, et al
     Clinical and Oncological Outcomes of Laparoscopic Lateral Pelvic Lymph Node Dissection in Advanced Lower Rectal Cancer: Single-institution Experience.
     Anticancer Res. 2017;37:5095-5100.
     PubMed     Text format     Abstract available
     
     
     
252. CARINI F, Mazzola M, Rappa F, Jurjus A, et al
     Colorectal Carcinogenesis: Role of Oxidative Stress and Antioxidants.
     Anticancer Res. 2017;37:4759-4766.
     PubMed     Text format     Abstract available
     
     
     
253. BAR JK, Lis-Nawara A, Grelewski P, Noga L, et al
     The Association Between HSP90/topoisomerase I Immunophenotype and the Clinical Features of Colorectal Cancers in Respect to KRAS Gene Status.
     Anticancer Res. 2017;37:4953-4960.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: